About Us

  1. TOP
  2. Company


Company NameiPS Portal, Inc
FoundedJuly 31, 2014
Managing DirectorsCEO Masakazu Kobayashi
AddressLouis Pasteur Center for Medical Reserch, Bldg., 103-5 Tanaka Monzen-cho , Sakyo-ku, Kyoto 606-8225, Japan
Capital1.868 billion Yen (capital stock of 951,600,000 Yen, and capital reserve of 917,000,000 Yen)
Number of employees30  (as of the end of January 2021)

Corporate Governance

Director & Auditor
Shosaku Murayama
President & CEO
Masakazu Kobayashi
Senior Managing Director & COO
Hiroko Ota
Senior Managing Director & CFO
Takasei Yoshida
Finance Department CPA
Senior Managing Director & CTO
Hisako Kubo
Life Science Department
Managing Director
Hirotomo Kawano
Business Administration Department
Executive Director
Yoshio Yamaoka
Professor Emeritus, Kyoto University
Executive Director
Junya Toguchida
Professor, Laboratory of Tissue Regeneration, Institute for Frontier Life and Medical Sciences, Kyoto University
Corporate Auditor
Kozo Miseki
Corporate Auditor
Yoshito Fujikawa
Law/Patent Attorney
Advisory Board
Scientific Advisory Board Kenji Osafune Professor, Center for iPS Cell Research and Application, Kyoto University
Shimon Sakaguchi, Honorary Professor, Osaka University, and Honorary Professor, Kyoto University
Kohji Nishida, Professor & Chairman, Department of Ophthalmology, Graduate School of Medicine, Osaka University
Management Advisory Board Motoshige Ito, Honorary Professor, The University of Tokyo, and Professor, Gakushuin University
Richard C. Koo, Chief Researcher, Center for Strategic Management & Innovation, Nomura Research Institute
Consultants Hideo Saji, Honorary Professor, Kyoto University and Director, Kyoto University Research Administration Office
Masahiro Kino-oka, Professor, Graduate School of Engineering Osaka University
Pharmaceutical Affairs Consultants Shin Kawamata, Director & Chairman, Research & Development Center for Cell Therapy, Foundation for Biomedical Research and Innovation at Kobe
Zen-ichi Mohri, Regenerative Medicine Advisor for Development


iPS Portal Inc. began operations in September 2014, following the transfer of non-patent related operations of iPS Academia Japan, Inc. At the time of its establishment, iPS Portal Inc. focused on contract testing of iPS cells in efforts to promote the broad use of iPS cell technology. We also provide support for start-up companies related to Cell-Technology, and have been involved in the establishment and operation of Raymei, Inc., a corneal regenerative medicine company since 2016 and Houjou, Inc., a company that aims to protect endangered species and to commercialize fertility treatments since 2020. In January 2021, we moved our headquarters and laboratory to a new location, marking the next stage of our business.We will continue to contribute to the development of the life science field by supporting iPS cells and other Cell-Technology-based research and business from both technology and business perspectives, and by providing higher value-added services.


Please feel free to contact us if you have any questions or consultation.